---
title: "How has biotechnology advanced the field of pre-natal diagnostics?"
summary: "Biotechnology has advanced pre-natal diagnostics by enabling early detection of genetic disorders and chromosomal abnormalities in foetuses."
author: "Dr. Megan Harris"
degree: "PhD in Cellular Biology, University College London"
tutor_type: "IB Biology Tutor"
date: 2024-07-23
---

Biotechnology has significantly enhanced the field of pre-natal diagnostics, facilitating early detection of genetic disorders and chromosomal abnormalities in foetuses. 

The advent of sophisticated genetic testing methodologies has transformed pre-natal diagnostics, enabling healthcare professionals to identify a broad spectrum of genetic conditions and chromosomal irregularities. Key techniques include amniocentesis, chorionic villus sampling (CVS), and non-invasive prenatal testing (NIPT).

Amniocentesis and CVS are invasive procedures that involve obtaining samples from within the womb: amniocentesis collects amniotic fluid, while CVS involves extracting placental tissue. Both procedures can reveal chromosomal abnormalities, such as Down syndrome, and genetic disorders like cystic fibrosis and sickle cell anaemia. However, they come with a small risk of miscarriage.

Conversely, NIPT is a non-invasive approach that examines cell-free foetal DNA (cffDNA) circulating in the motherâ€™s bloodstream. This testing method can accurately identify trisomies (the presence of additional chromosomes) and other chromosomal abnormalities without the associated risks of invasive procedures. The introduction of NIPT represents a significant leap forward in pre-natal diagnostics, providing a safer and more precise alternative to traditional testing methods.

Additionally, biotechnology has paved the way for pre-implantation genetic diagnosis (PGD). This technique is used alongside in-vitro fertilisation (IVF) to screen embryos for genetic disorders prior to implantation in the uterus. PGD offers parents who are carriers of specific genetic conditions the opportunity to increase their likelihood of having a healthy child.

Moreover, advancements in biotechnology have resulted in enhanced imaging techniques. For example, 3D and 4D ultrasounds provide detailed visualizations of the foetus, allowing for the identification of physical abnormalities that may suggest underlying genetic disorders.

In summary, the progress made in biotechnology has greatly improved both the accuracy and safety of pre-natal diagnostics. These innovations have enabled the early detection of genetic disorders and chromosomal abnormalities during pregnancy, all while minimizing risks for both the mother and the foetus.
    